Cellergy Pharma: Attacking Severe Allergies
August 8, 2024
Cellergy Pharma is working to cure severe allergic diseases, including two large, underserved severe allergic disease markets (uncontrollable severe allergic asthma and severe food allergy), by using novel cancer-fighting CAR T cells that target and ...
chat_bubble0 Comment
visibility80 Views
Premier Digital Partners
© 2024 Delaware Business Times
